Martin Rogers is a successful start-up investor and company director. Martin has Chemical Engineering and Computer Science degrees and has a depth of experience in incubating companies and publicly listed organisations.
Martin has experience in all aspects of financial, strategic and operational management. Martin has been both an investor and senior executive in a private funded advisory business in the tech, science and life sciences sectors, where he was instrumental in significantly increasing the value of those investments.
Martin was instrumental in the establishment of KTM Ventures, an ESVCLP (Early Stage Venture Capital Limited Partnership) incorporated under Australian law with tax advantages to venture investors. KTM Ventures provides potentially higher investment returns in a tax-effective fund focused upon pre-IPO and private expansion capital.
Martin's recent board positions include: Chairman, Actinogen (ASX:ACW) and Rhinomed (ASX:RNO), Non-Executive Director OncoSil Medical (ASX:OSL) and Cellmid (ASX:CDY). Prior to this Martin was the CEO for Prima BioMed Ltd (ASX:PRR).
To view KTM Ventures Innovation Fund, please visit:
Australia's First Regulated Cryptocurrency Exchange:
To view the Video Webcast, please visit:
To view Martins Full Presentation PDF, please visit:
Investorium.tv is a Video Streaming and Live Financial Industry Event featuring CEOs of Public Companies held at Premier Venues in New York, Vancouver and Sydney. Investorium.tv records and video streams the events on "state of the art" digital recording and webcasting equipment, making high definition broadcast quality productions available to Members and the professional investment community.
Mission NewEnergy Limited